NASDAQ:QIPT Quipt Home Medical - QIPT Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $6.53 +0.05 (+0.77%) (As of 03/21/2023 04:23 PM ET) Add Compare Share Share Today's Range$6.49▼$6.5650-Day Range$5.50▼$6.6252-Week Range$3.89▼$6.70Volume44,665 shsAverage Volume99,301 shsMarket Capitalization$235.34 millionP/E Ratio32.65Dividend YieldN/APrice Target$11.75 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Quipt Home Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside80.2% Upside$11.75 Price TargetShort InterestHealthy1.00% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.71Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth66.67%From $0.24 to $0.40 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.38 out of 5 starsMedical Sector211th out of 988 stocksSurgical & Medical Instruments Industry17th out of 101 stocks 3.5 Analyst's Opinion Consensus RatingQuipt Home Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $11.75, Quipt Home Medical has a forecasted upside of 80.2% from its current price of $6.52.Amount of Analyst CoverageQuipt Home Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.00% of the float of Quipt Home Medical has been sold short.Short Interest Ratio / Days to CoverQuipt Home Medical has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Quipt Home Medical has recently decreased by 15.29%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldQuipt Home Medical does not currently pay a dividend.Dividend GrowthQuipt Home Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for QIPT. Previous Next 0.7 News and Social Media Coverage News SentimentQuipt Home Medical has a news sentiment score of -0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Quipt Home Medical this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for QIPT on MarketBeat in the last 30 days. This is a decrease of -92% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Quipt Home Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Quipt Home Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.20% of the stock of Quipt Home Medical is held by insiders.Percentage Held by InstitutionsOnly 26.14% of the stock of Quipt Home Medical is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Quipt Home Medical are expected to grow by 66.67% in the coming year, from $0.24 to $0.40 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quipt Home Medical is 32.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.18.Price to Earnings Ratio vs. SectorThe P/E ratio of Quipt Home Medical is 32.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 98.72.Price to Book Value per Share RatioQuipt Home Medical has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Quipt Home Medical (NASDAQ:QIPT) StockQuipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company also provides bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, nebulizers and compressors, oxygen concentrators, patient lifts, walkers, wheelchairs, and products for wound care. In addition, it offers ventilators; home-based sleep apnea and chronic obstructive pulmonary disease treatments; home-based healthcare logistics and services; medical supplies, medical equipment, mobility equipment, and respiratory equipment; and CPAP and BiPAP units, ventilation equipment and aids, daily and ambulatory aides, and equipment solutions, as well as home and hospital delivery, and oxygen therapy services. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.Read More Receive QIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address QIPT Stock News HeadlinesMarch 21, 2023 | finance.yahoo.comReturns On Capital Are Showing Encouraging Signs At Quipt Home Medical (CVE:QIPT)March 16, 2023 | americanbankingnews.comBeyond Air (NASDAQ:XAIR) vs. Quipt Home Medical (NASDAQ:QIPT) Critical ReviewMarch 21, 2023 | Investing Daily (Ad)Check Out This 6-Year Win StreakDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. February 21, 2023 | finance.yahoo.comQuipt Home Medical Named as a Top Performing Company to the 2023 TSX Venture 50 ListFebruary 14, 2023 | msn.comQuipt Home Medical GAAP EPS of $0.01 in-line, revenue of $40.8MFebruary 10, 2023 | msn.comPreview: Quipt Home Medical's EarningsFebruary 8, 2023 | finance.yahoo.comQuipt Home Medical Corp.'s (CVE:QIPT) Stock Is Going Strong: Have Financials A Role To Play?January 9, 2023 | uk.finance.yahoo.comAnalysts Just Made An Incredible Upgrade To Their Quipt Home Medical Corp. (CVE:QIPT) ForecastsMarch 21, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...December 27, 2022 | finance.yahoo.comQuipt Home Medical reports 36.6% revenue gain in 2022 amid record-setting fourth quarterDecember 21, 2022 | finance.yahoo.comQuipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2022 Financial Results Posting Positive Net Income, Revenue Growth of 37% and Adjusted EBITDA Growth of 37%December 20, 2022 | msn.comEarnings Outlook For Quipt Home MedicalDecember 14, 2022 | finance.yahoo.comQuipt Home Medical Announces Date and Time for Q4 and Full Year Fiscal 2022 Conference Call and Audio WebcastNovember 1, 2022 | theglobeandmail.comQuipt Home Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (QIPT)September 20, 2022 | bizjournals.comQuipt Home Medical closes oversubscribed $110M financing round with CIT BankAugust 18, 2022 | finance.yahoo.comQuipt Home Medical Corp. (CVE:QIPT) Just Released Its Third-Quarter Earnings: Here's What Analysts ThinkAugust 16, 2022 | seekingalpha.comQuipt Home Medical Corp. (QIPT) CEO Greg Crawford on Q3 2022 Results - Earnings Call TranscriptAugust 11, 2022 | finance.yahoo.comQuipt Home Medical to Participate at the Sidoti Virtual Investor Conference on August 17th – 18thAugust 9, 2022 | finance.yahoo.comUPDATE -- Quipt Announces Early Conversion of 2019 Convertible Debentures Strengthening Balance SheetAugust 3, 2022 | finance.yahoo.comQuipt Home Medical Announces Date and Time for Fiscal Q3 2022 Conference Call and Audio WebcastJuly 19, 2022 | finance.yahoo.comQuipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th - 11thJuly 11, 2022 | finance.yahoo.comQuipt Surpasses 200,000 Active Patients Adding Approximately $7 Million in Annualized Revenues, and Anticipated $1.4 Million of Adjusted EBITDA Post IntegrationJune 21, 2022 | finance.yahoo.comQuipt Enters Louisiana Adding Approximately $6.5 Million in Annualized Revenues, and Anticipated $1.3 Million of Adjusted EBITDA (post integration) with Acquisition of Access Respiratory Homecare, LLCJune 9, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine Quipt Home Medical Corp. (CVE:QIPT)?June 7, 2022 | finance.yahoo.comQuipt Expands in California with Acquisition of NorCal Respiratory Reaching 90 Locations NationwideMay 19, 2022 | finance.yahoo.comQuipt Home Medical to Present at the LD Micro InvitationalMay 17, 2022 | seekingalpha.comQuipt Home Medical Corp. (QIPT) CEO Greg Crawford on Q2 2022 Results - Earnings Call TranscriptSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive QIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address QIPT Company Calendar Last Earnings2/13/2023Today3/21/2023Next Earnings (Estimated)5/15/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:QIPT CUSIPN/A CIK1540013 Webwww.protechhomemedical.com Phone859-878-2220FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Forecast$11.75 High Stock Price Forecast$14.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+80.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio32.60 Forward P/E Ratio27.17 P/E GrowthN/ANet Income$4.84 million Net Margins4.83% Pretax Margin3.69% Return on Equity9.94% Return on Assets5.78% Debt Debt-to-Equity Ratio0.18 Current Ratio1.05 Quick Ratio0.60 Sales & Book Value Annual Sales$139.86 million Price / Sales1.68 Cash Flow$0.78 per share Price / Cash Flow8.31 Book Value$2.23 per share Price / Book2.92Miscellaneous Outstanding Shares36,040,000Free Float34,523,000Market Cap$234.98 million OptionableNot Optionable Beta0.60 Key ExecutivesMr. Gregory J. CrawfordChairman, Pres & CEOMr. Hardik MehtaChief Financial OfficerMr. Jerry KirnVP of OperationsMr. David BachelderExec. VP of OperationsMr. William Todd Zehnder (Age 48)Chief Strategy Officer & Investor Relations Cole StevensVP of Corp. Devel. & VP of Investor RelationsLeslie BeckerExec. VP of Bus. Devel.Dr. William Dana Frazier M.D. (Age 65)Chief Medical Officer Mr. Mark MilesVP of Information TechnologyMr. Thomas W. Roehrig (Age 57)Exec. VP of Fin. More ExecutivesKey CompetitorsSurmodicsNASDAQ:SRDXProfound MedicalNASDAQ:PROFAlpha Tau MedicalNASDAQ:DRTSAccurayNASDAQ:ARAYBeyond AirNASDAQ:XAIRView All CompetitorsInstitutional OwnershipFirst Manhattan Co.Bought 75,000 shares on 2/15/2023Ownership: 2.778%Morgan StanleyBought 6,669 shares on 2/15/2023Ownership: 0.019%Susquehanna International Group LLPBought 53,252 shares on 2/14/2023Ownership: 0.179%O Shaughnessy Asset Management LLCBought 15,704 shares on 2/10/2023Ownership: 0.108%Bank of America Corp DESold 20,065 shares on 2/10/2023Ownership: 0.017%View All Institutional Transactions QIPT Stock - Frequently Asked Questions Should I buy or sell Quipt Home Medical stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quipt Home Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" QIPT shares. View QIPT analyst ratings or view top-rated stocks. What is Quipt Home Medical's stock price forecast for 2023? 3 equities research analysts have issued 12-month price objectives for Quipt Home Medical's shares. Their QIPT share price forecasts range from $10.00 to $14.00. On average, they expect the company's stock price to reach $11.75 in the next twelve months. This suggests a possible upside of 80.2% from the stock's current price. View analysts price targets for QIPT or view top-rated stocks among Wall Street analysts. How have QIPT shares performed in 2023? Quipt Home Medical's stock was trading at $4.71 on January 1st, 2023. Since then, QIPT shares have increased by 38.4% and is now trading at $6.52. View the best growth stocks for 2023 here. Are investors shorting Quipt Home Medical? Quipt Home Medical saw a decline in short interest in February. As of February 28th, there was short interest totaling 347,900 shares, a decline of 15.3% from the February 13th total of 410,700 shares. Based on an average trading volume of 82,100 shares, the short-interest ratio is presently 4.2 days. Currently, 1.0% of the company's shares are sold short. View Quipt Home Medical's Short Interest. When is Quipt Home Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023. View our QIPT earnings forecast. How were Quipt Home Medical's earnings last quarter? Quipt Home Medical Corp. (NASDAQ:QIPT) released its quarterly earnings results on Monday, February, 13th. The company reported $0.01 EPS for the quarter, hitting the consensus estimate of $0.01. The firm had revenue of $40.82 million for the quarter, compared to the consensus estimate of $41.27 million. Quipt Home Medical had a trailing twelve-month return on equity of 9.94% and a net margin of 4.83%. What is Quipt Home Medical's stock symbol? Quipt Home Medical trades on the NASDAQ under the ticker symbol "QIPT." Who are Quipt Home Medical's major shareholders? Quipt Home Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include CLARET ASSET MANAGEMENT Corp (11.42%), First Manhattan Co. (2.78%), Russell Investments Group Ltd. (1.84%), Boston Partners (1.03%), First Eagle Investment Management LLC (0.98%) and ARS Investment Partners LLC (0.24%). How do I buy shares of Quipt Home Medical? Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Quipt Home Medical's stock price today? One share of QIPT stock can currently be purchased for approximately $6.52. How much money does Quipt Home Medical make? Quipt Home Medical (NASDAQ:QIPT) has a market capitalization of $234.98 million and generates $139.86 million in revenue each year. The company earns $4.84 million in net income (profit) each year or $0.20 on an earnings per share basis. How can I contact Quipt Home Medical? The official website for the company is www.protechhomemedical.com. The company can be reached via phone at 859-878-2220 or via email at investorinfo@myquipt.com. This page (NASDAQ:QIPT) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.